Location History:
- Mundelein, IL (US) (1998 - 2003)
- Longmont, CO (US) (2003 - 2007)
- Spring Grove, IL (US) (2013 - 2014)
Company Filing History:
11 out of 2,483 
3 out of 1,152 
1 out of 15,475 
Years Active: 1998-2014
Title: Innovations by Kenneth E Burhop: A Profile of an Inventor in Pharmaceutical Advancements
Introduction
Kenneth E Burhop, an accomplished inventor based in Mundelein, IL, has made significant contributions to the field of pharmaceuticals with a total of 13 patents to his name. His innovative spirit is reflected in his latest breakthroughs, particularly in the formulation of esmolol, a medication used in critical care settings.
Latest Patents
Among his recent patents, two stand out prominently. The first is the patent for a "Multi-dose concentrate esmolol with benzyl alcohol," which presents a formulation of esmolol injection that is almost free from related esters and allows for versatile use as multi-dose compositions. This invention embodies a concentration range of 25-1000 mg/ml esmolol, combined with 1-25% w/v of benzyl alcohol. Additionally, it details methods for creating diluted, ready-to-use esmolol solutions from the concentrated form.
The second notable patent is the "Colored esmolol concentrate," which offers a means to distinguish concentrated esmolol formulations from their diluted counterparts. This advancement enhances patient safety and medication administration clarity, marking a significant step forward in pharmaceutical preparations.
Career Highlights
Throughout his career, Kenneth has had the privilege of working with prominent firms such as Baxter International Inc. and Baxter Healthcare S.A., where he has been able to channel his inventive talents into practical healthcare solutions. His work has not only improved drug formulations but has also set the stage for advancements in patient care.
Collaborations
Kenneth has collaborated with esteemed colleagues throughout his journey. Notably, he worked alongside Douglas L Looker and Izydor Z Apostol, fostering a creative environment that contributes to the innovative nature of their projects. Their collective efforts have resulted in impactful inventions that address critical healthcare needs.
Conclusion
Kenneth E Burhop's contributions to pharmaceutical innovations, particularly in esmolol formulations, exemplify the importance of invention in the medical field. With a solid foundation of patents and collaborations with esteemed professionals, Burhop continues to make strides that enhance medical treatments and patient outcomes. His work remains a testament to the power of innovation in improving healthcare solutions.